Joseph S Zakrzewski Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph S Zakrzewski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph S Zakrzewski. Joseph S Zakrzewski is in AMARIN CORP PLC\UK ($AMRN) and Director in AMARIN CORP PLC\UK ($AMRN) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and Director in INSULET CORP ($PODD) and Director in ACCELERON PHARMA INC ($XLRN) and Director in Cyteir Therapeutics, Inc. ($CYT).
Latest Insider Trading Transactions of Joseph S Zakrzewski
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, AMRN, CYT, PODD, SGMO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2021 | CYT | Cyteir Therapeutic ... | Zakrzewski Joseph S | Director | Option Exercise | C | 0.00 | 200,000 | 0 | 0 | |
| Jun 24 2021 | CYT | Cyteir Therapeutic ... | Zakrzewski Joseph S | Director | Buy | C | 0.00 | 58,671 | 0 | 58,671 | 0 to 58.7 K |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | M | 24.11 | 10,000 | 241,100 | 0 | |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 142.27 | 1,100 | 156,497 | 34,499 | 35.6 K to 34.5 K (-3.09 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 141.28 | 2,152 | 304,035 | 35,599 | 37.8 K to 35.6 K (-5.70 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 140.31 | 6,748 | 946,812 | 37,751 | 44.5 K to 37.8 K (-15.16 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | M | 24.11 | 10,000 | 241,100 | 44,499 | 34.5 K to 44.5 K (+28.99 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | M | 24.11 | 10,000 | 241,100 | 10,000 | |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 135.67 | 1,600 | 217,072 | 34,499 | 36.1 K to 34.5 K (-4.43 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 135.22 | 1,700 | 229,874 | 36,099 | 37.8 K to 36.1 K (-4.50 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 134.27 | 6,596 | 885,645 | 37,799 | 44.4 K to 37.8 K (-14.86 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 132.61 | 104 | 13,791 | 44,395 | 44.5 K to 44.4 K (-0.23 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | M | 24.11 | 10,000 | 241,100 | 44,499 | 34.5 K to 44.5 K (+28.99 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 8,200 | 0 | 48,200 | 40 K to 48.2 K (+20.50 %) |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 115.53 | 3,222 | 372,238 | 3,222 | |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,622 | 0 | 34,499 | 32.9 K to 34.5 K (+4.93 %) |
| Oct 22 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Option Exercise | M | 3.40 | 100,000 | 340,000 | 0 | ||
| Oct 22 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Buy | M | 3.40 | 100,000 | 340,000 | 184,547 | 84.5 K to 184.5 K (+118.28 %) | |
| Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Option Exercise | A | 0.00 | 27,191 | 0 | 27,191 | ||
| Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Option Exercise | A | 6.62 | 34,805 | 230,409 | 34,805 | ||
| Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Option Exercise | A | 0.00 | 27,191 | 0 | 27,191 | ||
| Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Option Exercise | A | 6.62 | 34,805 | 230,409 | 34,805 | ||
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 2,500 | 0 | 32,500 | 30 K to 32.5 K (+8.33 %) |
| Mar 19 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Buy | P | 4.99 | 5,000 | 24,950 | 30,000 | 25 K to 30 K (+20.00 %) |
| Mar 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Buy | P | 5.67 | 5,000 | 28,350 | 25,000 | 20 K to 25 K (+25.00 %) |
| Mar 13 2020 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Buy | P | 6.31 | 15,000 | 94,650 | 20,000 | 5 K to 20 K (+300.00 %) |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,377 | 0 | 32,877 | 31.5 K to 32.9 K (+4.37 %) |
| Jan 09 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | M | 3.88 | 18,750 | 72,750 | 0 | |
| Jan 09 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | M | 3.88 | 18,750 | 72,750 | 31,500 | 12.8 K to 31.5 K (+147.06 %) |
| Jan 03 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 300,000 | 1,020,000 | 100,000 | |
| Jan 03 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 20.94 | 300,000 | 6,282,870 | 84,547 | 384.5 K to 84.5 K (-78.01 %) |
| Jan 03 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 300,000 | 1,020,000 | 384,547 | 84.5 K to 384.5 K (+354.83 %) |
| Jan 03 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 300,000 | 1,020,000 | 100,000 | |
| Jan 03 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 20.94 | 300,000 | 6,282,870 | 84,547 | 384.5 K to 84.5 K (-78.01 %) |
| Jan 03 2020 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 300,000 | 1,020,000 | 384,547 | 84.5 K to 384.5 K (+354.83 %) |
| Dec 18 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 9.00 | 100,000 | 900,000 | 138,542 | |
| Dec 18 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 25.83 | 100,000 | 2,583,380 | 84,547 | 184.5 K to 84.5 K (-54.19 %) |
| Dec 18 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 9.00 | 100,000 | 900,000 | 184,547 | 84.5 K to 184.5 K (+118.28 %) |
| Jul 05 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 9.00 | 100,000 | 900,000 | 238,542 | |
| Jul 05 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 23.82 | 100,000 | 2,381,580 | 84,547 | 184.5 K to 84.5 K (-54.19 %) |
| Jul 05 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 9.00 | 100,000 | 900,000 | 184,547 | 84.5 K to 184.5 K (+118.28 %) |
| Jul 05 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 9.00 | 100,000 | 900,000 | 238,542 | |
| Jul 05 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 23.82 | 100,000 | 2,381,580 | 84,547 | 184.5 K to 84.5 K (-54.19 %) |
| Jul 05 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 9.00 | 100,000 | 900,000 | 184,547 | 84.5 K to 184.5 K (+118.28 %) |
| Jun 20 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 100,000 | 340,000 | 400,000 | |
| Jun 20 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 19.02 | 100,000 | 1,902,090 | 84,547 | 184.5 K to 84.5 K (-54.19 %) |
| Jun 20 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 100,000 | 340,000 | 184,547 | 84.5 K to 184.5 K (+118.28 %) |
| Jun 17 2019 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | P | 38.05 | 5,000 | 190,250 | 12,750 | 7.8 K to 12.8 K (+64.52 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
| May 21 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 0.00 | 7,428 | 0 | 7,428 | |
| May 21 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 16.83 | 9,658 | 162,544 | 9,658 | |
| Feb 22 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 8.10 | 36,875 | 298,688 | 0 | |
| Feb 22 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 8.86 | 143,750 | 1,273,625 | 0 | |
| Feb 22 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 19.90 | 180,625 | 3,594,438 | 84,547 | 265.2 K to 84.5 K (-68.12 %) |
| Feb 22 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 8.10 | 36,875 | 298,688 | 265,172 | 228.3 K to 265.2 K (+16.15 %) |
| Feb 22 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 8.86 | 143,750 | 1,273,625 | 228,297 | 84.5 K to 228.3 K (+170.02 %) |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,250 | 0 | 7,750 | 6.5 K to 7.8 K (+19.23 %) |
| Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 200,000 | 680,000 | 500,000 | |
| Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 17.96 | 100,000 | 1,796,080 | 84,547 | 184.5 K to 84.5 K (-54.19 %) |
| Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 16.00 | 100,000 | 1,600,310 | 184,547 | 284.5 K to 184.5 K (-35.14 %) |
| Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 200,000 | 680,000 | 284,547 | 84.5 K to 284.5 K (+236.55 %) |
| Jan 02 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 1.35 | 35,000 | 47,250 | 0 | |
| Jan 02 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 350,000 | 1,190,000 | 700,000 | |
| Jan 02 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 13.03 | 385,000 | 5,015,703 | 84,547 | 469.5 K to 84.5 K (-81.99 %) |
| Jan 02 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 1.35 | 35,000 | 47,250 | 469,547 | 434.5 K to 469.5 K (+8.05 %) |
| Jan 02 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 350,000 | 1,190,000 | 434,547 | 84.5 K to 434.5 K (+413.97 %) |
| Jan 02 2019 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 13.19 | 141,500 | 1,866,668 | 84,547 | 226 K to 84.5 K (-62.60 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 0.00 | 31,153 | 0 | 31,153 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 3.21 | 46,973 | 150,783 | 46,973 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 500,000 | 1,700,000 | 1,050,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 12.18 | 65,800 | 801,319 | 226,047 | 291.8 K to 226 K (-22.55 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 11.23 | 26,949 | 302,678 | 291,847 | 318.8 K to 291.8 K (-8.45 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 10.30 | 407,251 | 4,195,337 | 318,796 | 726 K to 318.8 K (-56.09 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 500,000 | 1,700,000 | 726,047 | 226 K to 726 K (+221.19 %) |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 15.65 | 15,000 | 234,750 | 15,000 | |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 40.61 | 7,500 | 304,575 | 7,500 | |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,250 | 0 | 6,500 | 5.3 K to 6.5 K (+23.81 %) |
| Jun 29 2017 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 8.70 | 30,000 | 261,000 | 30,000 | |
| May 18 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | A | 40.60 | 3,587 | 145,632 | 3,587 | |
| May 18 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 2,709 | 0 | 30,558 | 27.8 K to 30.6 K (+9.73 %) |
| May 17 2017 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 0.00 | 14,706 | 0 | 14,706 | |
| May 17 2017 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 3.06 | 21,146 | 64,707 | 21,146 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 30.17 | 7,500 | 226,275 | 7,500 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,250 | 0 | 5,250 | 4 K to 5.3 K (+31.25 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | M | 17.75 | 4,000 | 71,000 | 0 | |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | M | 20.90 | 4,000 | 83,600 | 0 | |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | M | 14.48 | 4,000 | 57,920 | 0 | |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | M | 7.06 | 18,480 | 130,469 | 0 | |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | M | 18.75 | 9,520 | 178,500 | 0 | |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Sell | S | 46.99 | 22,279 | 1,046,906 | 27,849 | 50.1 K to 27.8 K (-44.44 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Sell | S | 46.31 | 13,721 | 635,465 | 50,128 | 63.8 K to 50.1 K (-21.49 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Sell | S | 48.03 | 4,000 | 192,124 | 63,849 | 67.8 K to 63.8 K (-5.90 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Buy | M | 17.75 | 4,000 | 71,000 | 67,849 | 63.8 K to 67.8 K (+6.26 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Buy | M | 20.90 | 4,000 | 83,600 | 63,849 | 59.8 K to 63.8 K (+6.68 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Buy | M | 14.48 | 4,000 | 57,920 | 59,849 | 55.8 K to 59.8 K (+7.16 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Buy | M | 7.06 | 18,480 | 130,469 | 55,849 | 37.4 K to 55.8 K (+49.45 %) |
| Mar 03 2017 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Buy | M | 18.75 | 9,520 | 178,500 | 37,369 | 27.8 K to 37.4 K (+34.18 %) |
| Jan 03 2017 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | P | 25.50 | 4,000 | 102,000 | 4,000 | 0 to 4 K |
| Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 0.00 | 20,548 | 0 | 20,548 | |
| Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 2.19 | 28,847 | 63,175 | 28,847 | |
| May 13 2016 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | A | 28.87 | 5,235 | 151,134 | 5,235 | |
| May 13 2016 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 3,810 | 0 | 27,849 | 24 K to 27.8 K (+15.85 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 0.00 | 40,500 | 0 | 40,500 | |
| Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 2.50 | 23,144 | 57,860 | 23,144 | |
| Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 2.50 | 17,358 | 43,395 | 17,358 | |
| May 18 2015 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Option Exercise | A | 27.37 | 5,525 | 151,219 | 5,525 | |
| May 18 2015 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 4,039 | 0 | 24,039 | 20 K to 24 K (+20.20 %) |
Page: 1